TuHURA Biosciences Inc Corporate Update Call Transcript
Good morning and welcome to TuHURA Biosciences' corporate update call. With us today are Dr. James Bianco, CEO of TuHURA; Dan Dearborn, CFO of TuHURA; and Monique Kosse, IR for TuHURA. (Operator Instructions)
As a reminder, ladies and gentlemen, this conference call is being recorded, and your participation implies consent to our recording of this call. If you do not agree with these terms, please disconnect at this time.
Thank you. I would now like to turn the call over to Monique Kosse, Investor Relations for TuHURA Biosciences. Monique?
Thank you, Leo, and welcome, everyone. Before we begin, I would like to remind everyone that statements made during this call related to TuHURA's expected future performance, future business prospects, future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995.
Although the company believes that the expectations reflected in such forward-looking statements are based upon
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

